Page last updated: 2024-08-24

cephalosporin c and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

cephalosporin c has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Challa, HPR; Dubbudu, RR; Gupta, A; Kumar, LS; Reddy, PN; Sree, RA; Tirlangi, PK; Wanve, BS; Yadav, BS1
Egge, SL; Hakki, M; Lewis, JS1

Other Studies

2 other study(ies) available for cephalosporin c and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Successful Use of Cefepime-Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Infection in an Adult Patient with Acute T-Cell Leukemia.
    Antimicrobial agents and chemotherapy, 2023, 06-14

    Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Cephalosporins; Humans; Microbial Sensitivity Tests; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas aeruginosa; Pseudomonas Infections; Salvage Therapy

2023
Case Commentary: Successful Use of Cefepime/Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing
    Antimicrobial agents and chemotherapy, 2023, 08-17, Volume: 67, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactamases; Cefepime; Cephalosporins; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas aeruginosa; Pseudomonas Infections; Salvage Therapy

2023